Navigation Links
XTL Biopharmaceuticals Announces Receipt of NASDAQ Notice of Delisting
Date:1/28/2009

VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTL) today announced that on January 27, 2009 it received a Staff Determination Letter (the "Letter") from The Nasdaq Stock Market ("Nasdaq") notifying the Company that the staff of Nasdaq's Listing Qualifications Department determined, using its discretionary authority under Nasdaq Marketplace Rule 4300, that the Company's American Depository Shares ("ADRs") would be delisted from Nasdaq. The Letter further stated that Nasdaq would suspend trading in the Company's ADRs at the opening of trading on February 5, 2009 and then file a Form 25-NSE with the Securities and Exchange Commission ("SEC") to deregister the Company's ADRs, unless the Company appeals Nasdaq's delisting determination. Nasdaq's determination to delist the ADRs was based on Nasdaq's belief that the Company was a public shell and that the Company does not meet the stockholder's equity requirement or any of its alternatives.

The Letter also indicated that, in accordance with the procedures set out in Marketplace Rule 4800 Series, the Company would have seven (7) calendar days, or until February 3, 2009, to appeal the delisting from Nasdaq to a Listing Qualifications Panel. At this time, the Company does plan to appeal the delisting from Nasdaq. There can be no assurance that the appeal will be successful.


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
5. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
6. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
9. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
10. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
11. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... today the integration of Omicsoft’s Array Suite with ... platforms will be able to send data in tranSMART ... works with all versions of tranSMART including the new ... art statistics, visualization and storage for the analysis of ...
(Date:7/31/2014)... July 31, 2014 Although RNA-Sequencing ... the first transcriptome-wide analyses appearing around 2008, RNA-Sequencing ... for RNA measurement. In the last several years, ... specific, work with smaller input amounts, process degraded ... blood samples). On the bioinformatics side, there have ...
(Date:7/31/2014)... July 31, 2014   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade hypothermic storage ... precision thermal shipping products for cells and tissues, ... financial results will be released on Thursday, August 7, ... call and live webcast at 4:30 p.m. ET that ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The Kidney Cancer ... of its monthly news magazine, Kidney Cancer News. , ... presence on a website maintained by an international news organization. ... immediate increase in viewers.” , This month’s program highlights news ... tumors analyzed in a recent study. Kidney Cancer News ...
Breaking Biology Technology:Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2
... 16 Spherix Incorporated,(Nasdaq: SPEX ) has reported ... share) and $7.1 million ($0.50 per share) for the ... losses,exceeded the losses for the corresponding periods of 2006 ... clinical trial of Naturlose,as a treatment for type 2 ...
... German . , Many scientists are working ... production of tiny particles with defined size and shape ... or three dimensions and at both the nano- and ... modern technology, from diagnostic systems to the generation of ...
... status needed to initiate therapy with Pfizer,s recently ... Selzentry(TM) (Maraviroc), CCR5 antagonist, MALIBU, Calif., Nov. 15 ... Office (USPTO) has issued U.S. Patent,number 7,294,458 (the ,458 ... Care of HIV-1-Infected Patients." Pathway Diagnostics,has licensed the ,458 ...
Cached Biology Technology:Spherix Reports 3rd Quarter Earnings 2Two-faced miniatures 2Pathway Diagnostics Announces Patent Issuance for the Diagnostic Measurement of HIV Tropism for the Initiation or Modification of HIV Therapy 2
(Date:7/30/2014)... change on the world,s animal and plant species ... a new paper by a research team from ... other organizations. The authors claim that most of ... it comes to climate change. , While ... the "direct" threats of changing temperatures and precipitation ...
(Date:7/30/2014)... Governing Board of the Entomological Society of America (ESA) ... 2014. The election as a Fellow acknowledges outstanding contributions ... research, teaching, extension, or administration. The following Fellows will ... Meeting -- which will be held November 16-19, 2014 ... is a professor with the Department of Plant, ...
(Date:7/30/2014)... Life Sciences Institute (SALSI), a joint venture between The ... University of Texas Health Science Center at San Antonio, ... Program. The winners, Emily Boice from UTSA and Lei ... for their project titled, "Novel engineered ferritins for tracking ... Boice and Huang,s research is focused on finding a ...
Breaking Biology News(10 mins):Conservation scientists asking wrong questions on climate change impacts on wildlife 2Entomological Society of America recognizes 2014 fellows 2Entomological Society of America recognizes 2014 fellows 3Entomological Society of America recognizes 2014 fellows 4Entomological Society of America recognizes 2014 fellows 5Entomological Society of America recognizes 2014 fellows 6Entomological Society of America recognizes 2014 fellows 7Entomological Society of America recognizes 2014 fellows 8Entomological Society of America recognizes 2014 fellows 9Entomological Society of America recognizes 2014 fellows 10Entomological Society of America recognizes 2014 fellows 11Entomological Society of America recognizes 2014 fellows 12Entomological Society of America recognizes 2014 fellows 13Entomological Society of America recognizes 2014 fellows 14Entomological Society of America recognizes 2014 fellows 15Entomological Society of America recognizes 2014 fellows 16Entomological Society of America recognizes 2014 fellows 17
... HOLLYWOOD, Calif., Dec. 10, 2012  Medbox, Inc. (OTC Markets: ... trading volume of 54,468 shares and finishing the day ... On Friday, the company had announced formation ... The targeted market segments mentioned were: pharmaceutical packaging (prescription ...
... on children continue to become ever more apparent. A ... BMC Public Health shows that second hand ... pregnant significantly increase the risk of invasive meningococcal disease. ... bacterial meningitis, can also cause severe illness when bacteria, ...
... Researchers show that the global epidemic of Clostridium ... caused by the spread of two different but highly ... was previously thought. The spread and persistence of both ... a frontline antibiotic. Unlike many other healthcare-associated bacteria, ...
Cached Biology News:Medbox, Inc. Comments on Record Trading Day 2Medbox, Inc. Comments on Record Trading Day 3Second-hand smoke increases risk of invasive meningococcal disease in children 2Bugs without borders 2
... Intended Use: Vision Mount is formulated for ... producing alcohol soluble OR alcohol insoluble end products. , ... ... used with chromogens such as Fast-Red or AEC that require ...
... very potent Rnase free Ribonuclease ... a broad range of temperatures ... does not inhibit SP6, T7, ... and M-MLV reverse transcriptase or ...
... The BioLogic Maximizer kit, 110 to ... pH monitoring and doubles flow rates ... chromatography systems. The kit includes the ... mixer, starter kit, tubing kit, system ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
Biology Products: